Showing results (1-10 of 431) with videos related to
Sort By:
Pageof 44
Expert Review of Anti-Infective Therapy|December 5, 2022
Escalation of antimicrobial resistance among MRSA part 1: focus on global spreadJoseph P Lynch, George G ZhanelSeminars in Respiratory and Critical Care Medicine|January 3, 2006
Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapyJoseph P Lynch, George G ZhanelExpert Review of Anti-Infective Therapy|June 10, 2023
Part 2: mucormycosis: focus on therapyJoseph P Lynch, George G ZhanelSeminars in Respiratory and Critical Care Medicine|January 21, 2022
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for TherapyJoseph P Lynch, George G ZhanelCurrent Opinion in Pulmonary Medicine|April 9, 2010
Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccinesJoseph P Lynch, George G ZhanelSeminars in Respiratory and Critical Care Medicine|March 20, 2009
Streptococcus pneumoniae: epidemiology, risk factors, and strategies for preventionJoseph P Lynch, George G ZhanelExpert Review of Anti-Infective Therapy|December 5, 2022
Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatmentJoseph P Lynch, George G ZhanelSeminars in Respiratory and Critical Care Medicine|March 20, 2009
Streptococcus pneumoniae: does antimicrobial resistance matter?Joseph P Lynch, George G ZhanelExpert Review of Anti-Infective Therapy|October 9, 2023
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobialsColeman Rotstein, Joseph P Lynch, George G ZhanelSeminars in Respiratory and Critical Care Medicine|June 5, 2017
Emergence of Antimicrobial Resistance among Pseudomonas aeruginosa: Implications for TherapyJoseph P Lynch, George G Zhanel, Nina M ClarkPageof 44